Lateral Flow Rapid Testing Market Size, Key Players Analysis And Forecast To 2028

The Business Research Company published its Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Lateral Flow Immunoassay (LFIA) Based Rapid Test market.

The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the lateral flow immunoassay (LFIA) based rapid test market’s segments-1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay2) By End User: Hospital and Clinic, Diagnostic Laboratory, Home Care, Others3) By Application: Infectious Disease, Pregnancy and Fertility, Toxicology, Others.View Complete Report:https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-changeLateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.

The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.

The chapter also covers markets which have been positively affected by the pandemic.The global lateral flow immunoassay based rapid test market is expected to decline from $5.98 billion in 2019 to $5.77 billion in 2020 at a compound annual growth rate (CAGR) of -3.63%.

The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.

The entire supply chain has been disrupted, impacting the market negatively.

The global lateral flow assays market size is expected to reach USD 11.66 billion by 2028 at a CAGR of 4.6%, according to the latest report by Reports and Data.

Rising consumption rate for home-based lateral flow testing solutions and products, and growing requirement of better point-of-care testing products are a few major factors driving the revenue growth of the lateral flow assays market.

Moreover, the test can also be easily conducted by non-trained individuals due to its highly user-friendly form of testing.Increasing geriatric population leads to rising prevalence of different types of infectious diseases across the globe, which is one of the most crucial factors expected to propel the revenue growth of the lateral flow assays market during the forecasted period.However, lack of preference from consumers to shift from conventional diagnostic testing methods and adopting advanced methods is one of the significant factors predicted to restrain the market revenue growth to a certain extent between 2021 & 2028.Top Companies Profiled in the Report Include:Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), Rad Laboratories (U.S.), bioMérieux SA (France), Bio Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Quidel Corporation (U.S.), Hologic Inc. (U.S.), Merck KGaA (Germany), Abcam plc (UK).Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4086Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.

Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past.

In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4086The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R activities, and government and corporate deals, among others through extensive primary and secondary research.

The global Lateral Flow Immunoassay Reader Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.

Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the lateral flow immunoassay reader market include Abbott, Abingdon, QIAGEN, BD Company, Axxin, LRE Medical, Detekt Biomedical, Quidel Corporation, Magnasense, Skannex, OpTricon, Fio Corporation, NOWDiagnostics Inc, VICAM, IUL, Mobile Assay, Other.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Lateral Flow Immunoassay Reader Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/lateral-flow-immunoassay-reader-market/download-sampleMarket DynamicsThe high demand for rapid test readers that are simple to use, economical, and highly effective in obtaining non-subjective diagnostic test results at hospitals, laboratories, clinics, and other point-of-care locations is the primary stimulant for the growth of this market.

The ability to integrate these readers with a mobile device will be a market booster.

The broad spectrum of testing capabilities provided by these readers and easy integration with LIS and EMR databases will benefit market growth.